Insider sale
LANTERN PHARMA INC.
$249.8K
75.94K shares
What this filing means
BIOS FUND I, LP plans to sell 75.94K shares of LANTERN PHARMA INC. valued at approximately $249.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/27/2025ACC: 0001104659-25-053171
75.94K
Shares to sell
$249.8K
Approx. market value
564.04K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Conversion of Shares in IPO
Conversion
6/15/2020
564.04KTotal acquired564.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/15/2020 | Conversion of Shares in IPO Conversion | 564.04K | — |
| Total | 564.04K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
75.94K
Market value
$249.8K
5/27/2025
Total
Units
75.94K
Value
$249.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/27/2025 | 75.94K | $249.8K | NASDAQ | Planned |
| Total | 75.94K | $249.8K | ||